Researchers in the U.K. start developing vaccine to prevent ovarian cancer

Researchers in the U.K. have started developing a vaccine aimed at preventing ovarian cancer. This initiative is funded by Cancer Research UK and targets women with BRCA1 or BRCA2 gene mutations, who face a significantly higher risk of the disease. Currently, women with these mutations often undergo surgery to remove their ovaries, leading to early menopause. The new vaccine aims to train the immune system to recognize and attack abnormal ovarian cells, potentially offering a preventive option. The project uses ovarian cancer samples to identify common mutations that trigger immune responses. If successful, the vaccine could eventually be tested more broadly, but it will require several years of clinical trials before approval.